KYRA ROBINSON: Open Payments
NPI 1134820137 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $307 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $228 |
| Smith+Nephew, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Averitas Pharma Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, OASIS, NUCALA, QUTENZA, TEZSPIRE.
Industry payments across AL — which companies pay providers there.
